SCHEMBL10939180

SCHEMBL10939180

Oc1ccc(C2CNCCc3c2cc(O)c(O)c3F)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 15/20 0.73
▸ DRD2 P14416 9/20 0.73
▸ KDM4E B2RXH2 5/20 0.73
▸ RECQL P46063 4/20 0.73
▸ BLM P54132 3/20 0.73
▸ CYP3A4 P08684 2/20 0.73
▸ CYP2D6 P10635 2/20 0.73
▸ NFKB1 P19838 2/20 0.73
▸ THPO P40225 2/20 0.73
▸ HIF1A Q16665 2/20 0.73
▸ HSD17B10 Q99714 2/20 0.73
▸ MEN1 O00255 1/20 0.73
▸ CYP2C9 P11712 1/20 0.73
▸ TSHR P16473 1/20 0.73
▸ CYP2C19 P33261 1/20 0.73
▸ KMT2A Q03164 1/20 0.73
▸ KDM1A O60341 1/20 0.73
▸ HTR1A P08908 1/20 0.73
▸ ADRA2A P08913 1/20 0.73
▸ SLC6A2 P23975 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9162037 1.00 DRD1 (0.73) DRD1DRD2KDM4ERECQLBLM
Bromide SCHEMBL10938965 0.99 KDM4E (0.73) DRD1DRD2KDM4ERECQLBLM
SCHEMBL11163152 0.90 DRD1 (0.73) DRD1DRD2KDM4ERECQLBLM
SCHEMBL11609337 0.87 DRD1 (0.56) DRD1DRD2KDM4ERECQLBLM
Fenoldopam SCHEMBL34250 0.84 DRD1 (1.00) DRD1DRD2KDM4ERECQLBLM
Fenoldopam SCHEMBL13287212 0.84 DRD1 (1.00) DRD1DRD2KDM4ERECQLBLM
SCHEMBL11540532 0.84 DRD1 (0.81) DRD1DRD2KDM4ERECQLBLM
Fenoldopam SCHEMBL9157427 0.84 DRD1 (1.00) DRD1DRD2KDM4ERECQLBLM
Fenoldopam SCHEMBL41214 0.84 DRD1 (1.00) DRD1DRD2KDM4ERECQLBLM
Fenoldopam SCHEMBL1815791 0.84 DRD1 (1.00) DRD1DRD2KDM4ERECQLBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0081006-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING 7,8-DIHYDROXY-1(HYDROXYPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE DERIVATIVES AND A BETA-ADRENERGIC BLOCKING COMPOUND SMITHKLINE BECKMAN CORPORATION (US) 1985-09-25 — — EP claimed
US-4518609-A ANTITUMOR, SKIN DISORDERS SRI INTERNATIONAL (US) 1985-05-21 — — US disclosed
US-4456618-A ANTITUMOR AGENTS, TREATMENT OF SKIN DISORDERS SRI INTERNATIONAL (US) 1984-06-26 — — US disclosed
Send feedback